Results 141 to 150 of about 35,110 (216)

HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway

open access: yesDiscover Oncology
Homeobox B8 (HOXB8) belongs to the HOX family and was essential to the development of colorectal carcinoma. Among the prevalent monoclonal antibodies for treating RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients, cetuximab stands out, but ...
Yunan Liang   +5 more
doaj   +1 more source

Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer. [PDF]

open access: yesIndian J Otolaryngol Head Neck Surg, 2023
Chaudhary RK   +4 more
europepmc   +1 more source

Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity. [PDF]

open access: yesCancer Drug Resist, 2023
Zaryouh H   +14 more
europepmc   +1 more source

Combination of cetuximab with met inhibitor in control of cetuximab-resistant oral squamous cell carcinoma.

open access: yesAmerican journal of translational research
Objective: To investigate the underlying molecular mechanisms contributing to oral squamous cell carcinoma (OSCC) cell resistance to the epidermal growth factor receptor (EGFR) inhibitor. Materials and methods: OSCC cell lines HSC-2 and HSC-3 were assessed in vitro for drug treatment, cell viability, and gene expression and the online gene expression ...
Hua, Yang   +11 more
openaire   +1 more source

IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner. [PDF]

open access: yesCell Death Dis, 2023
Chen LJ   +14 more
europepmc   +1 more source

Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival. [PDF]

open access: yes, 2019
PurposeGenomic alterations in blood-derived circulating tumor DNA (ctDNA) from patients with colorectal cancers were correlated with clinical outcomes.Patients and methodsNext-generation sequencing of ctDNA (54- to 73-gene panel) was performed in 94 ...
Fanta, Paul T   +9 more
core   +1 more source

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma

open access: yesNature Communications
Anti-epidermal growth factor receptor (EGFR) therapy (cetuximab) shows a limited clinical benefit for patients with locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), due to the frequent occurrence of secondary ...
Valentin Van den bossche   +29 more
doaj   +1 more source

Home - About - Disclaimer - Privacy